3M littmann stethoscopes and eko collaborate to improve healthcare outcomes in patients

WORLD – 3M Littmann Stethoscopes, that deals in the production of medical devices and Eko digital innovations, a company specializing in artificial intelligence (AI), collaborate to deliver comprehensive healthcare solutions that will drive better patient outcomes. This is a collaboration that will see both companies try to meet the growing demand on auscultation in healthcare and the advancing digital technology by marrying 3M Littmann stethoscope technology with advanced Eko digital innovations. The collaboration has led to the development of an innovation, 3M Littmann Core digital stethoscope that offers clinicians access…

Read More

Zambia works in close collaboration with WHO to ensure successful rollout of cholera vaccines

ZAMBIA – Although Cholera is a preventable disease, it remains a significant public health problem globally. Each year, there are 1.3 to 4.0 million cases of cholera, and 21,000 to 143,000 deaths worldwide. Zambia has experienced cholera outbreaks since 1977 and the country’s last major outbreak lasted from October 2017 to June 2018 with a total of 5,935 reported cases and 114 deaths. The risk factors mainly include inadequate access to clean and safe water, poor sanitation facilities, poor solid waste management and consumption of contaminated food. In 2019 the…

Read More

E-commerce continues to fuel the ever-blooming healthcare logistics market in Africa

AFRICA – African e-commerce marketplaces are venturing into the delivery of health care products as part of a strategy to broaden their value to customers. These platforms are part of a broader crop of innovators at an interesting intersection of healthcare and logistics on the continent. Going by recent data, this sub-sector has grown over two years. At least 61 companies are using tech for health distribution across sub-Saharan Africa, a growth of over 100% in the number of active players (28) captured in 2018. That’s according to a report…

Read More

Kenya has five weeks to use over 350,000 AstraZeneca vaccine doses from Denmark

KENYA – The government of Kenya will need to expedite the deployment of 358,700 doses of the Astrazeneca Covid-19 vaccine donated by Denmark, which are to expire on July 31. The jabs arrived in Kenya on Monday night and were taken to the national vaccines store in Athi River for distribution. Head of vaccines deployment task force, Willis Akhwale, said despite the short expiry period, Kenya has one of the most efficient rollout plans. “So with these ones, and the capacity to even vaccinate 50,000 people per day, we believe…

Read More

Merck Foundation calls for action together with African First Ladies and Ministers to Build Healthcare Capacity

ZAMBIA – Merck foundation “More than a Mother” Ambassadors, African First Ladies of Angola, Botswana, Burkina Faso, Burundi, Central African Republic, Democratic Republic of Congo, Ghana, Guinea Conakry, Liberia, Malawi, Mozambique, and Namibia actively participated in the 8th edition of Merck Foundation Africa Asia Luminary which was co-chaired by Zambia First Lady, H.E. Esther Lungu and Merck Foundation CEO, Senator, Dr. Rasha Kelej. Merck Foundation, the philanthropic arm of Merck KgaA, conducted the 8th Edition of “Merck Foundation Africa Asia Luminary” 2021, through an online video conference. During the Luminary,…

Read More

Max Healthcare collaborates with digital health solutions to launch a remote healthcare monitoring system

INDIA – Max Healthcare, a giant Indian based corporation in the healthcare sector, has launched an artificial intelligence (AI) powered device integrated patient monitoring framework, claimed to be the first in the country. The project was a success owing to the fact that Max Healthcare collaborated with digital health solutions, an Indian social business that uses technology and creativity to make high-quality health services. This was a move Max Healthcare undertook in a bid to expand its geography of care, allowing patients from across India and globally to stay connected…

Read More

Delta COVID-19 strain detected in Ghana but community spread is yet to be detected

GHANA – The Ghana Health Service (GHS) says the Delta Coronavirus strain, originating from India, has been detected in Ghana through testing at the port health but there is currently no evidence of community spread. The service has said the strain was found through a generic analysis of samples collected form passengers who arrived at the Kotoka International Airport about a week ago. The number of delta strains detected in the country so far is however not known. Dr Franklin Asiedu-Bekoe, Director of Public Health, GHS, said that the Delta…

Read More

University of Oxford is currently studying ivermectin as a possible therapy against COVID-19 in the UK

UK – Researchers from the university of Oxford under the PRINCIPLE study project are currently giving Ivermectin, a widely used anti-parasitic drug, to over-50s with COVID symptoms to see if it can keep them out of hospital. PRINCIPLE is a nationwide clinical study from the University of Oxford in collaboration with the British government trying to find COVID-19 treatments for recovery at home. The project is currently having any willing citizen over-50s with an underlying health condition or experiencing breathlessness and have had COVID symptoms for up to 14 days…

Read More

Africa’s COVID-19 cases edge closer to the 5.3 million mark punctuated by a daily spike in infections

AFRICA – The number of confirmed COVID-19 cases in Africa has reached 5,234,387, the Africa Centers for Disease Control and Prevention (Africa CDC) reported. The Africa CDC, the specialized healthcare agency of the African Union, said the death toll from the pandemic stood at 138,154 while 4,643,802 patients across the continent had recovered from the disease. South Africa, Morocco, Tunisia, Ethiopia and Egypt are the countries with the most cases in the continent, according to the Africa CDC. South Africa has 1,832,479 cases and 58,795 deaths. The country has received…

Read More

BioNTech’s BNT111 phase 2 clinical trial makes progress as patient with advanced Melanoma treated

GERMANY – BioNTech, a German pharmaceutical company, has announced that the first patient has been treated in its BNT111 phase 2 cancer medication trial. Currently, the study is evaluating the Company’s therapeutic cancer vaccine candidate BNT111 in combination with Libtayo (cemiplimab), an anti-PD-1 monoclonal antibody, in patients with anti-PD1-refractory/relapsed unresectable Stage III or IV melanoma. Melanoma is a type of skin cancer that develops when melanocytes (the cells that give the skin its tan or brown color) start to grow out of control or can be refereed to hyperpigmentation. BNT111…

Read More